Outcomes'10
Clinical trials sponsored by Outcomes'10, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New oxygen device may make endoscopy safer for High-Risk patients Results expected Oct 2026 (estimated)
- New study tracks how doctors treat malnutrition in diabetes patients Results expected Oct 2026 (estimated)
- Blood thinner safety during polyp removal put to the test Results expected Nov 2026 (estimated)
-
Blood thinner safety during polyp removal put to the test
Disease control OngoingThis study looks at whether it's safe to continue taking blood-thinning medication during the removal of colon polyps. About 481 adults on blood thinners will be randomly assigned to either keep taking their medication or stop temporarily before the procedure. Researchers will tr…
Phase 4 • Sponsor: Outcomes'10 • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New supplement aims to fight malnutrition in cancer patients
Disease control By invitation onlyThis study looks at whether a special drink made with easily digested protein and MCT oil can help improve malnutrition in cancer patients who are having radiotherapy. The study will follow 132 adults with head and neck, lung, rectal, or esophageal cancer for 12 weeks. Researcher…
Sponsor: Outcomes'10 • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New oxygen device may make endoscopy safer for High-Risk patients
Symptom relief By invitation onlyThis study tests whether high-flow oxygen therapy can prevent low oxygen levels (hypoxemia) in patients at higher risk during sedated digestive endoscopy. The trial includes 326 adults with obesity, sleep apnea, or stable lung or heart conditions. Researchers will compare high-fl…
Phase 4 • Sponsor: Outcomes'10 • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC